Advanced search

Phase 2 studies of immunochemotherapy +/- bortezomib (VC) in newly diagnosed non-germinal center B-cell-like (GCB) DLBCL: rapid prospective identification of non-GCB patients (PTS)

(2011) ANNALS OF ONCOLOGY. 22(suppl. 4). p.225-225
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Offner, Fritz, B Ferhanoglu, JA Reeves, HS Eom, K Doner, J Raposo, IW Flinn, et al. 2011. “Phase 2 Studies of Immunochemotherapy +/- Bortezomib (VC) in Newly Diagnosed Non-germinal Center B-cell-like (GCB) DLBCL: Rapid Prospective Identification of non-GCB Patients (PTS).” In Annals of Oncology, 22:225–225.
APA
Offner, F., Ferhanoglu, B., Reeves, J., Eom, H., Doner, K., Raposo, J., Flinn, I., et al. (2011). Phase 2 studies of immunochemotherapy +/- bortezomib (VC) in newly diagnosed non-germinal center B-cell-like (GCB) DLBCL: rapid prospective identification of non-GCB patients (PTS). ANNALS OF ONCOLOGY (Vol. 22, pp. 225–225). Presented at the 11th International conference on Malignant Lymphoma.
Vancouver
1.
Offner F, Ferhanoglu B, Reeves J, Eom H, Doner K, Raposo J, et al. Phase 2 studies of immunochemotherapy +/- bortezomib (VC) in newly diagnosed non-germinal center B-cell-like (GCB) DLBCL: rapid prospective identification of non-GCB patients (PTS). ANNALS OF ONCOLOGY. 2011. p. 225–225.
MLA
Offner, Fritz, B Ferhanoglu, JA Reeves, et al. “Phase 2 Studies of Immunochemotherapy +/- Bortezomib (VC) in Newly Diagnosed Non-germinal Center B-cell-like (GCB) DLBCL: Rapid Prospective Identification of non-GCB Patients (PTS).” Annals of Oncology. Vol. 22. 2011. 225–225. Print.
@inproceedings{2119874,
  author       = {Offner, Fritz and Ferhanoglu, B and Reeves, JA and Eom, HS and Doner, K and Raposo, J and Flinn, IW and Suh, C and Chowhan, NM and Prasad, S and Kussick, SJ and Mulligan, G and Rizo, A and Leonard, JP},
  booktitle    = {ANNALS OF ONCOLOGY},
  issn         = {0923-7534},
  language     = {eng},
  location     = {Lugano, Switzerland},
  number       = {suppl. 4},
  pages        = {225--225},
  title        = {Phase 2 studies of immunochemotherapy +/- bortezomib (VC) in newly diagnosed non-germinal center B-cell-like (GCB) DLBCL: rapid prospective identification of non-GCB patients (PTS)},
  volume       = {22},
  year         = {2011},
}

Web of Science
Times cited: